TPBG
LRCX icon

Turning Point Benefit Group’s Lam Research LRCX Stock Holding History

Turning Point Benefit Group’s Portfolio LRCX Stock Details LRCX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-894
Closed -$153K – 496
2025
Q4 		$153K Sell
894
-174
-16% -$27.1K 0.08% 104
2025
Q3 		$153K Buy
+1,068
New +$113K 0.09% 94

Other funds holding LRCX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Turning Point Benefit Group's LRCX Position: Q1 2026 in Review

Turning Point Benefit Group sold out of Lam Research (LRCX) in Q1 2026, closing a stake of 894 shares — an estimated $153K sold.

Turning Point Benefit Group first reported a position in LRCX in Q3 2025 and held it in 2 quarters. The position peaked at $153K in Q4 2025. 2,630 funds tracked by Wall St. Rank hold LRCX as of Q1 2026.

  • Turning Point Benefit Group reported no remaining Lam Research position as of Q1 2026 after selling out during the quarter.
  • Turning Point Benefit Group sold 894 Lam Research shares in Q1 2026, an estimated $153K.
  • Turning Point Benefit Group first reported a position in Lam Research in Q3 2025 and held it in 2 quarters.
  • Turning Point Benefit Group's Lam Research position peaked at $153K in Q4 2025.
  • 2,630 funds tracked by Wall St. Rank held Lam Research as of Q1 2026.

Based on Turning Point Benefit Group's 13F filing for Q1 2026, filed 12 May 2026.